The Pharmacologic Management of Cardiac Arrest.

Megan Heeney, Martha E Montgomery, Amandeep Singh

Journal: Cardiology clinics 2024;42(2):279-288

PMID: 38631795

Full Text on Elsevier Science View on PubMed

Abstract

The effectiveness of pharmacologic management of cardiac arrest patients is widely debated; however, several studies published in the past 5 years have begun to clarify some of these issues. This article covers the current state of evidence for the effectiveness of the vasopressor epinephrine and the combination of vasopressin-steroids-epinephrine and antiarrhythmic medications amiodarone and lidocaine and reviews the role of other medications such as calcium, sodium bicarbonate, magnesium, and atropine in cardiac arrest care. We additionally review the role of β-blockers for refractory pulseless ventricular tachycardia/ventricular fibrillation and thrombolytics in undifferentiated cardiac arrest and suspected fatal pulmonary embolism.

Address: Alameda Health System, Highland Hospital Emergency Department, 1411 East 31st Street, Oakland, CA 94602, USA. Electronic address: [email protected].; Alameda Health System, Highland Hospital Emergency Department, 1411 East 31st Street, Oakland, CA 94602, USA.

DOI: 10.1016/j.ccl.2024.02.012

Link outs

Free resources

Medical:

https://medlineplus.gov/cpr.html

Miscellaneous:

https://assays.cancer.gov/CPTAC-68

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Heart Arrest, Anti-Arrhythmia Agents, Amiodarone, Lidocaine, Epinephrine, Ventricular Fibrillation, Cardiopulmonary Resuscitation